Last reviewed · How we verify

Green Tea Leaf Extract Decaffeinated

Ain Shams University · Phase 3 active Small molecule

Green tea leaf extract decaffeinated delivers polyphenols, primarily catechins and EGCG, which act as antioxidants and anti-inflammatory agents to reduce oxidative stress and modulate cellular signaling pathways.

At a glance

Generic nameGreen Tea Leaf Extract Decaffeinated
SponsorAin Shams University
Drug classBotanical extract / Polyphenol antioxidant
ModalitySmall molecule
PhasePhase 3

Mechanism of action

The active compounds in decaffeinated green tea extract, particularly epigallocatechin gallate (EGCG) and other catechins, scavenge free radicals and inhibit pro-inflammatory cytokine production. These polyphenols modulate multiple signaling pathways including NF-κB and MAPK, potentially reducing tissue damage and supporting cellular health across various disease states.

Approved indications

No approved indications tracked.

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results